Ticker Symbol: CHRS
Coherus Biosciences Inc
$18.98 - 02-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001512762
Company Profile
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients' lives and to deliver significant savings to the health care system.
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 333 Twin Dolphin Dr Ste 600
Website: www.coherus.com
CEO: Dennis Lanfear
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $3.54
Change:
-$0.01
(
-0.28%)
Days Range: $3.49 - $3.64
Beta: 1.56
52wk. High: $10.99
52wk. Low: $3.14
Ytd. Change -55.46%
50 Day Moving Average: $4.18
200 Day Moving Average: $5.07
Shares Outstanding: 94468493
Valuation
Market Cap: 33.4B
PE Ratio: -1.08
EPS (TTM): -3.28
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A